ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658103; 2) Community: the network communities that were significantly associated with the response to NSC 658103; 3) Molecule: the relationships between components within communities and NSC 658103; 4) MDR: the compounds that were significantly associated with the NSC 658103.

NSC Compound Enrichment Correlation
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0295480456086945 0.53657456
NSC 750685 Null 0.0295480456086945 0.25365844
NSC 90810 Null 0.0295480456086945 0.41974403
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0295480456086947 0.54526826
NSC 13484 Null 0.0295480456086947 0.12549722
NSC 135073 WITHACNISTIN 0.0295480456086947 0.40765015
NSC 261726 ICN 4221 0.0295480456086947 0.35780876
NSC 287069 Epicorazine A 0.0295480456086947 0.35431105
NSC 295499 Camptothecin Derivative 0.0295480456086947 0.69580228
NSC 408171 Null 0.0295480456086947 -0.0043348266
Total:83  Current:53    [First] [Prev] [Next] [Last]